Design, Synthesis, and Anti-Hepatocellular Carcinoma Evaluation Revealed by Transcriptome Analysis of Epimeric Sesquiterpene Lactones: Trilobolide-6- O -isobutyrate Analogues
Journal of Natural Products · 2025
DOI: 10.1021/acs.jnatprod.5c00279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Natural Products, 2025. Verfasst von Xiu-Qiao Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education, Hainan Normal University, Haikou 571126, Hainan, People's Republic …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Lactones, Liver Neoplasms, Sesquiterpenes. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Key Research and Development Project of Hainan Province, Natural Science Foundation of Hainan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Hepatocellular carcinoma is a malignant neoplasm that ranks sixth in global incidence and fourth in global mortality. In this study, based on the splicing principle and prodrug synthesis strategies, a total of 18 new sesquiterpene lactone derivatives, consisting of seven mustard derivatives and 11 amine adducts, were designed and synthesized using the sesquiterpene lactone epimers 1 and 2 as parent molecules. Their structures were characterized by means of NMR, HRESIMS, and X-ray crystallography data. Through the CCK8 assay, compound 11 exhibited the most potent inhibitory activity against HepG2 (IC50 = 4.2 μM) and Huh7 (IC50 = 4.9 μM) cells. Subsequent pharmacological experiments demonstrated that compound 18 could decrease the viability of two HCC cell lines in a time- and dose-dependent manner. Both compounds 11 and 18 were capable of inducing cell apoptosis, arresting the cell cycle progression, and inhibiting cell proliferation and migration in HepG2 and Huh7 cells. Further transcriptome analysis indicated that 18 possessed potential antitumor effects. Both 11 and 18 had favorable predicted ADME and physicochemical properties. Collectively, the findings of this study suggest that derivatives 11 and 18 are promising candidates for the treatment of hepatocellular carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education, Hainan Normal University, Haikou 571126, Hainan, People's Republic of China.
- Key Laboratory of Tropical Medicinal Plant Chemistry of Hainan Province, College of Chemistry and Chemical Engineering, Hainan Normal University, Haikou 571126, Hainan, People's Republic of China.
- College of Science, Hainan Tropical Ocean University, Sanya 572022, Hainan, People's Republic of China.
ORCID-Profile: Xiu-Qiao Zhou, Wen-Hao Chen
Förderung
- Key Research and Development Project of Hainan Province
- Natural Science Foundation of Hainan Province
- National Natural Science Foundation of China
- Specific Research Fund of the Innovation Platform for Academicians of Hainan Province
Zitieren
APA
Zhou, X. Q., Qian, Y. M., Li, X., Jiang, C. J., Feng, H. J., He, H. Q., Zeng, H. Z., Hui, Y., & Chen, W. H. (2025). Design, Synthesis, and Anti-Hepatocellular Carcinoma Evaluation Revealed by Transcriptome Analysis of Epimeric Sesquiterpene Lactones: Trilobolide-6- O -isobutyrate Analogues. Journal of Natural Products. https://doi.org/10.1021/acs.jnatprod.5c00279
Vancouver
Zhou XQ, Qian YM, Li X, Jiang CJ, Feng HJ, He HQ, et al. Design, Synthesis, and Anti-Hepatocellular Carcinoma Evaluation Revealed by Transcriptome Analysis of Epimeric Sesquiterpene Lactones: Trilobolide-6- O -isobutyrate Analogues. Journal of Natural Products. 2025. doi:10.1021/acs.jnatprod.5c00279
BibTeX
@article{Zhou2025,
author = {Zhou, Xiu-Qiao and Qian, Yi-Ming and Li, Xing and Jiang, Chui-Ji and Feng, Hua-Jie and He, Hui-Qian and Zeng, Hao-Zhe and Hui, Yang and Chen, Wen-Hao},
title = {Design, Synthesis, and Anti-Hepatocellular Carcinoma Evaluation Revealed by Transcriptome Analysis of Epimeric Sesquiterpene Lactones: Trilobolide-6- O -isobutyrate Analogues},
journal = {Journal of Natural Products},
year = {2025},
doi = {10.1021/acs.jnatprod.5c00279}
}
EUVIMED